Active Ingredient: PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM
Proprietary Name: BLEPHAMIDE
Dosage Form; Route of Administration: SUSPENSION; OPHTHALMIC
Strength: 0.2%;10%
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N012813
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ALLERGAN PHARMACEUTICAL
Marketing Status:
Discontinued
Patent and Exclusivity Information
